Scientific Congresses

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases by contributing to cutting-edge research. Below, you can find Dyne-sponsored posters and oral presentations from global congresses.

The FORCE™ platform, zeleciment-basivarsen (z-basivarsen, also known as DYNE-101), zeleciment-rostudirsen (z-rostudirsen, also known as DYNE-251), DYNE-302, and DYNE-401 are investigational or otherwise in development and have not been approved as safe or effective by the US FDA, EMA or any other regulatory authority.